fig1
Figure 1. Glucose metabolic reprogramming regulates sensitivity to antitumor therapy. cGAS/STING: Cyclic GMP-AMP synthase/stimulator of interferon gene; ERK/AKT: extracellular regulated protein kinases/protein kinase B; HK2: hexokinase 2; PGK1: phosphoglycerate kinase 1; PKM2: pyruvate kinase M2; HIF-1α: hypoxia-inducible factor-1α; PEKB3: phosphofructokinase-2/fructose-2,6-biphosphatase 3; LDHA: lactate dehydrogenase A; c-Myc: cellular Myc; ALODA: aldolase A.
